期刊文献+

^131I治疗前刺激性Tg对乳头状甲状腺癌远处转移的预测价值 被引量:48

The value of pre-ablation stimulated thyroglobulin in predicting distant metastasis of papillary thyroid cancer
原文传递
导出
摘要 目的探讨刺激性Tg在乳头状甲状腺癌(PTC)术后、^131I治疗前对远处转移的预测价值。方法231例经过甲状腺全切术拟行”^131I治疗的PTC患者,根据是否存在远处转移分为M1[38例,男15例,女23例,平均年龄(43.9±16.3)岁]和M0[193例,男60例,女133例,平均年龄(42.4±11.4)岁]2组。用t检验及,检验观察2组的年龄、性别差异是否有统计学意义,用Mann.Whitney秩和检验比较2组间Tg水平,通过ROC曲线及最佳诊断界值点(DCP)评估刺激性Tg对远处转移的预测价值。结果2组的年龄(t=-0.675,P=0.50)、性别(X^2=1.02,P=0.31)差异均无统计学意义。2组刺激性Tg水平分别为1.5~17.5μG/L和93.8~1000.0μg/L,两者差异有统计学意义(U=787.5,P〈0.001)。Tg的RO CAUC为0.893(95%CI:0.823-0.962),Tg界值点为52.75μg/L,对应的灵敏度、特异性分别为78.90%和91.70%。结论刺激性Tg在PTC全切术后、^131I治疗前对PTC的远处转移有首要的预测价值. Objective To investigate the value of pre-ablation stimulated Tg in predicting distant metastasis of papillary thyroid cancer (PTC). Methods The study included 231 patients with PTC who had undergone total thyroidectomy and subsequent 131I therapy. Patients were divided into two groups as MI (38 cases, 15 males, 23 females, average age (43.9± 16.3) y) and M0 (193 cases, 60 males, 133 remales, average age (42.4 ± 11.4) y) according to the presence and absence of distant metastases, respectively. T-test andx2 test were used to evaluate the statistical differences between the two groups. The Tg value between M0 and M1 was compared by Mann-Whitney rank-sum test. The ROC curves and diagnostic critical point (DCP) were analyzed to evaluate the predictive value of stimulated Tg. Results There was no significant difference between the two groups in age ( t = - 0. 675, P = 0.50) and gender (X2 = 1.02, P = 0.31 ). Pre-ablation stimulated Tg was significantly different between the two groups (the Mann-Whitney rank-sum test : U = 787.5, P 〈 0. 001 ). Area under the ROC curve for Tg levels was 0. 893 (95% CI: 0. 863 - 0.962). The cut-off value of DCP of Tg was 52.75 μg/L with a sensitivity of 78.90% and specificity of 91.70%. Conclusion Stimulated Tg may be a useful "diagnostic tumor marker" for predicting distant metastases of PTC before the first ^131 I ablation therapy.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2012年第3期189-191,共3页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 甲状腺肿瘤 乳头状 甲状腺球蛋白 碘放射性同位素 Thyroid neoplasms Carcinoma, papillary Thyroglobulin Iodine radioisotopes
  • 相关文献

参考文献10

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid:Official Journal of the American Thyroid Association,2009.1167-1214.
  • 2Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management[J].Clinical Chemistry and Laboratory Medicine,2008.1067-1073.
  • 3Salvatori M,Raffaelli M,Castaldi P. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma[J].European Journal of Surgical Oncology,2007,(5):648-654.doi:10.1016/j.ejso.2007.02.034.
  • 4Makarewicz J,Adanczewski Z,Knapska-Kucharska M. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery[J].Experimental and Clinical Endocrinology & Diabetes,2006,(9):485-489.doi:10.1055/s-2006-951778.
  • 5Sampson E,Brierley JD,Le LW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis[J].Cancer,2007.1451-1456.doi:10.1002/cncr.22956.
  • 6张桂芝,谭建,刘雪辉,孟召伟.131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J].中华核医学杂志,2010(4):259-263. 被引量:44
  • 7田蓉,匡安仁,秦卫仕,张辉敏.分化型甲状腺癌患者^(131)I治疗后全身显像的临床价值[J].中华核医学杂志,2000,20(4):162-164. 被引量:20
  • 8Suh I,Vriens MR,Guerrero MA. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthlecell neoplasms of the thyroid[J].American Journal of Surgery,2010.41-46.doi:10.1016/j.amjsurg.2009.08.030.
  • 9Phan HT,Jager PL,van der Wal JE. The follow-up of patients with differentiated thyroid cancer and undeteetable thyroglobulin (Tg) and Tg antibodies during ablation[J].European Journal of Endocrinology,2008.77-83.doi:10.1530/EJE-07-0399.
  • 10Tourniaire J,Bernard MH,Ayzac L. Serum thyroglobulin assay after total unilateral thyroid lobectomy for differentiated thyroid cancer[J].Presse Medicale,1990.1309-1312.

二级参考文献13

  • 1Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002.J Am Med Assoc,2006,295:2164-2167.
  • 2Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16:109-142.
  • 3Lundgren CI,Hall P,Dickman PW,et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:a populationbased,nested case-control study.Cancer,2006,106:524-531.
  • 4Jukkola A,Bloigu R,Ebeling T,et al.Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.Endocr Relat Cancer,2004,11:571-579.
  • 5Bilimoria KY,Bentrem DJ,Ko CY,et al.Extent of surgery affects survival for papillary thyroid cancer.Ann Surg,2007,246:375-381.
  • 6Do MY,Rhee Y,Kim DJ,et al.Clinical features of bone metastases resulting from thyroid cancer:a review of 28 patients over a 20-year period.Endocr J,2005,52:701-707.
  • 7Kumar A,Bal CS.Differentiated thyroid cancer.Indian J Pediatr,2003,70:707-713.
  • 8Mazzaferri EL,Robbins RJ,Spencer CA,et al.A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.J Clin Endocrinol Metab,2003,88:1433-1441.
  • 9Kim TY,Kim WB,Kim ES,et al.Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.J Clin Endocrinol Metab,2005,90:1440-1445.
  • 10Spencer CA,Bergoglio LM,Kazarosyan M,et al.Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.J Clin Endocrinol Metab,2005,90:5566-5575.

共引文献62

同被引文献204

引证文献48

二级引证文献571

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部